Samsung Medical Center
Brain tumor treatment cost in the Republic of Korea is generally determined by the surgical approach and diagnostic complexity. A brain MRI with contrast typically costs Price on request to Price on request , while primary brain tumor surgery runs from $19,500 to $46,000. Total expenses depend on the tumor stage, technology used, and hospital tier. Patients often find 30-50% savings compared to the US. Top cities for these procedures include Seoul and Incheon.
Typical Brain Tumor Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients requiring high-precision intervention should consider Samsung Medical Center for its advanced Novalis and IGRT technologies. For those seeking standardized digital safety, Seoul National University Bundang Hospital utilizes the BESTcare system to minimize medical errors. Complex multidisciplinary cases benefit from Asan Medical Center, which manages massive patient volumes with specialized oncology teams. JCI-accredited facilities like Severance Hospital offer premium care standards for international patients from the USA and UAE.
| Republic of Korea | Turkey | Austria | |
| Radiation therapy for brain tumor | from $31,771 | from $2,000 | from $15,000 |
| Proton-beam therapy | from $22,000 | from $70,000 | from $80,000 |
| Gamma Knife for brain tumor | from $12,709 | from $4,750 | from $25,000 |
| Gamma Knife | from $13,500 | from $4,300 | from $32,000 |
| CyberKnife for brain tumor | from $11,500 | from $4,750 | from $35,000 |
Dr. Han Yeongmin is a neurosurgeon (MD, PhD). He is Medical Director and Director of the Neurosurgery Center at Incheon St. Mary’s Hospital. He treats cerebrovascular disease and peripheral nerve disorders. He also specializes in brain tumors and skull base surgery. Conditions include stroke, cerebral hemorrhage, cerebral infarction, and moyamoya disease. He performs PEN, PNP, and SNB. He also offers microscopic and endoscopic discectomy, artificial disc replacement, MIS-TLIF/minimally invasive spinal fusion, and vertebroplasty.
He earned his MD and PhD from The Catholic University of Korea. He served as a visiting professor in cerebrovascular and skull base surgery at Barrow Neurological Institute (Phoenix, Arizona, USA). He also served at Harborview Medical Center, University of Washington (Seattle, USA).
His publications include co-authorship of Chapter 52 of the Textbook of Korean Cerebrovascular Surgery. He also co-authored Acoustic Neuroma Oncology. He is a full member of KNS, KSCVS, KSBS, KBTS, KNTS, KSNS, and KSPNS.
Dr. Yang Se Yeon is a neurosurgeon and Head of the Department of Neurosurgery at Naeun Hospital. He specializes in cerebral infarction, cerebral hemorrhage, cerebral aneurysm, moyamoya disease, carotid artery stenosis, vascular dizziness, and head trauma.
He graduated from The Catholic University of Korea College of Medicine. He also earned a Master’s in Medicine there. He completed an internship and a neurosurgery residency at Catholic Medical Center. He then completed a clinical fellowship and served as a clinical assistant professor at Uijeongbu St. Mary’s Hospital.
He has served as a staff neurosurgeon at the Northern Gyeonggi Regional Trauma Center. He was also Head of Neurosurgery at G-SAM Hospital.
Dr. Paik Nam-sun is a surgical oncologist at Ewha Womans University Medical Center in Seoul. He is recognized as one of the world's top 100 gastric and breast cancer surgeons. He performed the first breast-conserving surgery in South Korea. Dr. Paik also invented a proprietary stomach cancer technique to reduce reflux disease risk.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital (SNUH) are the premier institutions for brain tumor treatment in South Korea. These JCI-accredited and Newsweek-ranked facilities utilize advanced Novalis radiosurgery, Gamma Knife, and proton beam therapy to treat complex malignancies with high precision.
Bookimed Expert Insight: While Samsung Medical Center and SNUH are top-rated, SNU Bundang Hospital offers a unique safety advantage. It was South Korea's first fully digital hospital. Their BESTcare system significantly reduces medical errors in complex neurosurgery. This digital integration is the reason they maintain such high safety ratings despite serving 1,500,000 patients annually.
Patient Consensus: Patients recommend checking for English-speaking coordinators at SNUH early in the process. Many also note that securing local lodging in Seoul beforehand is vital for a smooth recovery period.
The 5-year survival rate for primary central nervous system tumors in South Korea is 86.4%. Clinical success rates for benign brain tumors reach 95% efficacy for surgical removal. Outcomes at high-volume centers often exceed global averages due to advanced intraoperative imaging and multidisciplinary protocols.
Bookimed Expert Insight: Patient volume is the most reliable predictor of success in Korea. Asan Medical Center treats over 2,500 inpatients daily and Seoul National University Hospital sees 10,700 patients. This massive scale allows surgeons at these JCI-accredited hubs to specialize in rare tumor subtypes that smaller clinics rarely encounter.
Patient Consensus: Patients emphasize that Korean neurosurgeons often achieve clean margins in complex glioblastoma cases where others could not. Many recommend prioritizing centers with proton therapy or intraoperative MRI for the best long-term remission results.
Korean hospitals use high-precision technologies like intraoperative MRI and 5-ALA fluorescence-guided surgery to maximize tumor removal. Non-surgical options include heavy ion therapy and ZAP-X gyroscopic radiosurgery. These tools allow surgeons to differentiate malignant cells from healthy tissue with sub-millimeter accuracy in JCI-accredited Seoul facilities.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital manage massive patient volumes, reaching up to 4,000,000 visits annually. This scale allows these centers to implement rare technologies like Novalis and heavy ion therapy much faster than smaller regional clinics. If you require specialized radiation, prioritize these high-volume Seoul centers for the most experienced technical teams.
Patient Consensus: Patients note that 5-ALA technology is more widely available in Korea than in many Western hospitals. They also emphasize that proton beam therapy significantly reduced side effects like hair loss and nausea compared to standard radiation.
Brain tumor surgery in the Republic of Korea typically requires a hospital stay of 4 to 7 days. Most patients return to normal activities within 6 to 12 weeks. Leading Seoul centers utilize minimally invasive techniques to accelerate recovery and minimize postoperative downtime.
Bookimed Expert Insight: High-volume centers like Asan Medical Center and Severance Hospital perform over 30,000 to 65,000 annual operations. Our data shows these institutions prioritize early rehabilitation protocols immediately after the ICU phase. This aggressive mobilization often reduces total hospital stays by 2 days compared to global averages. Patients at Samsung Medical Center benefit from presidential-standard care, which often includes integrated digital monitoring to catch postoperative edema early.
Patient Consensus: Patients note that while the physical incision heals quickly, brain fog and fatigue often linger for several months. Many emphasize that a temporary slump during steroid tapering at 4 weeks is a normal part of the process.
Patients with inoperable brain tumors in South Korea have access to advanced non-surgical treatments like Gamma Knife, CyberKnife, and proton-beam therapy. These technologies deliver high-precision radiation to delicate areas like the brainstem. Systemic medical therapies and dedicated tumor-treating fields further expand treatment options.
Bookimed Expert Insight: Analysis of South Korean oncology centers shows a clear preference for digital integration to enhance safety. Facilities like Samsung Medical Center and Seoul National University Hospital utilize IGRT and AI-driven imaging. This digitalization allows specialists to manage high volumes, with some treating over 10,000 patients daily while maintaining precision.
Patient Consensus: Patients highlight that proton therapy in Korea often involves shorter wait times than in the US. They note that stereotactic radiosurgery is a preferred first-line choice for small, hard-to-reach tumors.